{
    "Disease activity (follow up: 1 year; assessed with: DAS28-ESR (Lower values – > benefit) (MCID -1.17)": {
        "No of studies": [
            "1",
            "2"
        ],
        "Study design": "randomised trials ",
        "Risk of bias": [
            "serious",
            "a"
        ],
        "Inconsistency": [
            "not serious",
            "b"
        ],
        "Indirectness": "not serious ",
        "Imprecision": [
            "serious",
            "c"
        ],
        "Other considerations": "none",
        "No of patients": {
            "MTX monotherapy": "104",
            "SSZ": "102"
        },
        "Effect": {
            "Relative (95% CI)": "-",
            "Absolute (95% CI)": "MD 0.14 higher(0.18 lower to 0.47 higher)"
        },
        "Certainty": "LOW ",
        "Importance": "CRITICAL"
    },
    "Disability (follow up: 1 year; assessed with: HAQ-DI (Lower values – > benefit) (MCID -0.22)": {
        "No of studies": [
            "1",
            "2"
        ],
        "Study design": "randomised trials ",
        "Risk of bias": [
            "serious",
            "a"
        ],
        "Inconsistency": "not serious ",
        "Indirectness": "not serious ",
        "Imprecision": [
            "serious",
            "c"
        ],
        "Other considerations": "none",
        "No of patients": {
            "MTX monotherapy": "104",
            "SSZ": "102"
        },
        "Effect": {
            "Relative (95% CI)": "-",
            "Absolute (95% CI)": "MD 0.04 lower(0.2 lower to 0.13 higher)"
        },
        "Certainty": "LOW ",
        "Importance": "IMPORTANT"
    },
    "Pain (follow up: 1 year; assessed with: VAS 0-100 (Lower values – > benefit) (MCID -11.9)": {
        "No of studies": [
            "2"
        ],
        "Study design": "randomised trials ",
        "Risk of bias": "not serious",
        "Inconsistency": "not serious ",
        "Indirectness": "not serious ",
        "Imprecision": [
            "very serious",
            "d"
        ],
        "Other considerations": "none",
        "No of patients": {
            "MTX monotherapy": "35",
            "SSZ": "34"
        },
        "Effect": {
            "Relative (95% CI)": "-",
            "Absolute (95% CI)": "MD 0.1 higher(13.46 lower to 13.66 higher)"
        },
        "Certainty": "LOW ",
        "Importance": "IMPORTANT"
    },
    "Serious adverse events (follow up: 1 year)": {
        "No of studies": [
            "2"
        ],
        "Study design": "randomised trials ",
        "Risk of bias": "not serious",
        "Inconsistency": "not serious ",
        "Indirectness": "not serious ",
        "Imprecision": [
            "very serious",
            "d"
        ],
        "Other considerations": "none",
        "No of patients": {
            "MTX monotherapy": "0/35 (0.0%)",
            "SSZ": "3/34 (8.8%)"
        },
        "Effect": {
            "Relative (95% CI)": "RR 0.14(0.01 to 2.59) ",
            "Absolute (95% CI)": "76 fewer per 1,000(from 87 fewer to 140 more)"
        },
        "Certainty": "LOW ",
        "Importance": "IMPORTANT"
    },
    "Withdrawal due to lack of efficacy (follow up: 1 year)": {
        "No of studies": [
            "1",
            "2"
        ],
        "Study design": "randomised trials ",
        "Risk of bias": [
            "serious",
            "a"
        ],
        "Inconsistency": "not serious ",
        "Indirectness": "not serious ",
        "Imprecision": [
            "very serious",
            "e"
        ],
        "Other considerations": "none",
        "No of patients": {
            "MTX monotherapy": "5/104 (4.8%)",
            "SSZ": "10/102 (9.8%) "
        },
        "Effect": {
            "Relative (95% CI)": "RR 0.51(0.19 to 1.39)",
            "Absolute (95% CI)": "48 fewer per 1,000(from 79 fewer to 38 more) "
        },
        "Certainty": "VERY LOW ",
        "Importance": "IMPORTANT"
    },
    "Withdrawal due to adverse events (follow up: 1 year)": {
        "No of studies": [
            "1",
            "2"
        ],
        "Study design": "randomised trials ",
        "Risk of bias": [
            "serious",
            "a"
        ],
        "Inconsistency": [
            "not serious",
            "f"
        ],
        "Indirectness": "not serious ",
        "Imprecision": [
            "serious",
            "g"
        ],
        "Other considerations": "none",
        "No of patients": {
            "MTX monotherapy": "9/104 (8.7%)",
            "SSZ": "19/102 (18.6%)"
        },
        "Effect": {
            "Relative (95% CI)": "RR 0.46(0.22 to 0.98) ",
            "Absolute (95% CI)": "101 fewer per 1,000(from 145 fewer to 4 fewer) "
        },
        "Certainty": "LOW ",
        "Importance": "IMPORTANT"
    }
}